Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc + Combivir in Naive R5 HIV-1 Patients in Russia
NCT01275625Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Jun 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Jun 2011; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01275625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01275625.